Alamar Biosciences, Inc. Common Stock (ALMR) is a publicly traded the market company. As of May 21, 2026, ALMR trades at $20.16 with a market cap of $1.45B and a P/E ratio of 0.00. ALMR moved -1.51% today. Year to date, ALMR is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $20.02 to $27.20. Analyst consensus is strong buy with an average price target of $30.00. Rallies surfaces ALMR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent ALMR insider activity includes Illumina Innovation Fund II GP, L.L.C. bought 235.29K and Naclerio Nicholas bought 235.29K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $20.16 |
| Market Cap | $1.45B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.20 |
| 52-Week Low | $20.02 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover ALMR: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.00.